Table 4.
Best response, n (%) | De novo patients (n = 327) | Recurrent patients (n = 674) |
---|---|---|
Complete response | 70 (21.4) | 105 (15.6) |
Partial response/stable disease | 201 (61.5) | 385 (57.1) |
Progressive disease | 48 (14.7) | 162 (24.0) |
No assessment | 8 (2.4) | 22 (3.3) |
Best observed response confirmed by clinical symptoms, physical examination, or radiology